Trusted Resource for Clinical Trials, Protocols & Progress
What is a SUSAR and When to Report It? Understanding SUSARs and Their Reporting Requirements in Clinical Trials Introduction: Why SUSARs Matter in Clinical Trials In global clinical research, adverse event (AE) reporting is central to ensuring participant safety and regulatory compliance. Among the categories of AEs, one of the most critical is the Suspected…
Reconciliation of SAE Timelines Across Regions Reconciliation of SAE Timelines Across Global Regions in Clinical Trials Why Reconciliation of SAE Timelines Is Necessary Clinical trials are increasingly multinational, spanning the United States, European Union, United Kingdom, India, and other regions. Each jurisdiction enforces specific rules for Serious Adverse Event (SAE) and Suspected Unexpected Serious Adverse…
Read More “Reconciliation of SAE Timelines Across Regions” »
Key Distinctions Between SAE and SUSAR in Clinical Trials Understanding the Difference Between SAEs and SUSARs in Clinical Trials Defining SAE and SUSAR Serious Adverse Events (SAEs) and Suspected Unexpected Serious Adverse Reactions (SUSARs) are fundamental categories in clinical trial safety reporting. While both represent critical safety events, their definitions and reporting obligations differ. An…
Read More “Key Distinctions Between SAE and SUSAR in Clinical Trials” »
